These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


358 related items for PubMed ID: 15737435

  • 1. Inducible expression and pharmacological characterization of recombinant rat NR1a/NR2A NMDA receptors.
    Kurkó D, Dezso P, Boros A, Kolok S, Fodor L, Nagy J, Szombathelyi Z.
    Neurochem Int; 2005 Apr; 46(5):369-79. PubMed ID: 15737435
    [Abstract] [Full Text] [Related]

  • 2. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors.
    Williams K.
    Mol Pharmacol; 1993 Oct; 44(4):851-9. PubMed ID: 7901753
    [Abstract] [Full Text] [Related]

  • 3. Functional in vitro characterization of CR 3394: a novel voltage dependent N-methyl-D-aspartate (NMDA) receptor antagonist.
    Losi G, Lanza M, Makovec F, Artusi R, Caselli G, Puia G.
    Neuropharmacology; 2006 Mar; 50(3):277-85. PubMed ID: 16236334
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells.
    Priestley T, Laughton P, Myers J, Le Bourdellés B, Kerby J, Whiting PJ.
    Mol Pharmacol; 1995 Nov; 48(5):841-8. PubMed ID: 7476914
    [Abstract] [Full Text] [Related]

  • 5. Inducible expression and pharmacology of recombinant NMDA receptors, composed of rat NR1a/NR2B subunits.
    Nagy J, Boros A, Dezso P, Kolok S, Fodor L.
    Neurochem Int; 2003 Jul; 43(1):19-29. PubMed ID: 12605879
    [Abstract] [Full Text] [Related]

  • 6. Postnatal switching of NMDA receptor subunits from NR2B to NR2A in rat facial motor neurons.
    Xing GG, Wang R, Yang B, Zhang D.
    Eur J Neurosci; 2006 Dec; 24(11):2987-92. PubMed ID: 17156360
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological analysis of recombinant NR1a/2A and NR1a/2B NMDA receptors using the whole-cell patch-clamp method.
    Fodor L, Nagy J.
    Methods Mol Biol; 2007 Dec; 403():3-13. PubMed ID: 18827984
    [Abstract] [Full Text] [Related]

  • 8. Characterization of the effects of polyamines on [125I]MK-801 binding to recombinant N-methyl-D-aspartate receptors.
    Sharma TA, Reynolds IJ.
    J Pharmacol Exp Ther; 1999 May; 289(2):1041-7. PubMed ID: 10215685
    [Abstract] [Full Text] [Related]

  • 9. Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors.
    Bettini E, Sava A, Griffante C, Carignani C, Buson A, Capelli AM, Negri M, Andreetta F, Senar-Sancho SA, Guiral L, Cardullo F.
    J Pharmacol Exp Ther; 2010 Dec; 335(3):636-44. PubMed ID: 20810618
    [Abstract] [Full Text] [Related]

  • 10. Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells.
    Bresink I, Benke TA, Collett VJ, Seal AJ, Parsons CG, Henley JM, Collingridge GL.
    Br J Pharmacol; 1996 Sep; 119(2):195-204. PubMed ID: 8886398
    [Abstract] [Full Text] [Related]

  • 11. In vitro characterization of novel NR2B selective NMDA receptor antagonists.
    Kiss L, Cheng G, Bednar B, Bednar RA, Bennett PB, Kane SA, McIntyre CJ, McCauley JA, Koblan KS.
    Neurochem Int; 2005 May; 46(6):453-64. PubMed ID: 15769547
    [Abstract] [Full Text] [Related]

  • 12. Counteraction by repetitive daily exposure to static magnetism against sustained blockade of N-methyl-D-aspartate receptor channels in cultured rat hippocampal neurons.
    Hirai T, Taniura H, Goto Y, Tamaki K, Oikawa H, Kambe Y, Ogura M, Ohno Y, Takarada T, Yoneda Y.
    J Neurosci Res; 2005 May 15; 80(4):491-500. PubMed ID: 15846781
    [Abstract] [Full Text] [Related]

  • 13. Comparative pharmacology of the human NMDA-receptor subtypes R1-2A, R1-2B, R1-2C and R1-2D using an inducible expression system.
    Feuerbach D, Loetscher E, Neurdin S, Koller M.
    Eur J Pharmacol; 2010 Jul 10; 637(1-3):46-54. PubMed ID: 20394742
    [Abstract] [Full Text] [Related]

  • 14. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
    Ilyin VI, Whittemore ER, Guastella J, Weber E, Woodward RM.
    Mol Pharmacol; 1996 Dec 10; 50(6):1541-50. PubMed ID: 8967976
    [Abstract] [Full Text] [Related]

  • 15. Differential expression of NMDA and AMPA receptor subunits in rat dorsal and ventral hippocampus.
    Pandis C, Sotiriou E, Kouvaras E, Asprodini E, Papatheodoropoulos C, Angelatou F.
    Neuroscience; 2006 Jun 19; 140(1):163-75. PubMed ID: 16542781
    [Abstract] [Full Text] [Related]

  • 16. Toxicity of beta-amyloid in HEK293 cells expressing NR1/NR2A or NR1/NR2B N-methyl-D-aspartate receptor subunits.
    Domingues A, Almeida S, da Cruz e Silva EF, Oliveira CR, Rego AC.
    Neurochem Int; 2007 May 19; 50(6):872-80. PubMed ID: 17403555
    [Abstract] [Full Text] [Related]

  • 17. Lack of functional expression of NMDA receptors in PC12 cells.
    Edwards MA, Loxley RA, Williams AJ, Connor M, Phillips JK.
    Neurotoxicology; 2007 Jul 19; 28(4):876-85. PubMed ID: 17572500
    [Abstract] [Full Text] [Related]

  • 18. Knockdown of the aryl hydrocarbon receptor attenuates excitotoxicity and enhances NMDA-induced BDNF expression in cortical neurons.
    Lin CH, Chen CC, Chou CM, Wang CY, Hung CC, Chen JY, Chang HW, Chen YC, Yeh GC, Lee YH.
    J Neurochem; 2009 Nov 19; 111(3):777-89. PubMed ID: 19712055
    [Abstract] [Full Text] [Related]

  • 19. Subunit-specific potentiation of recombinant N-methyl-D-aspartate receptors by histamine.
    Williams K.
    Mol Pharmacol; 1994 Sep 19; 46(3):531-41. PubMed ID: 7935335
    [Abstract] [Full Text] [Related]

  • 20. Proteolysis of the N-methyl-d-aspartate receptor by calpain in situ.
    Guttmann RP, Sokol S, Baker DL, Simpkins KL, Dong Y, Lynch DR.
    J Pharmacol Exp Ther; 2002 Sep 19; 302(3):1023-30. PubMed ID: 12183659
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.